Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) ...

Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug ...

Allarity Therapeutics ( ($ALLR) ) has shared an update. On June 2, 2025, Allarity Therapeutics announced the enrollment of the first patient in ...

Results, presented simultaneously in oral presentation at ASCO 2025 and in peer-reviewed Gynecologic Oncology, suggest very meaningful survival effect of IMNN-001 in women HRP and HRD positive, ...

To address the challenge of controlling protein activation in living animals for gain-of-function studies, researchers from ...

Therapeutics announced that the first patient has been enrolled in its new Phase 2 clinical trial protocol of stenoparib for the ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

By balancing supply and demand in real time, the facility not only enhances grid reliability but also supports the ...

This paper delves into the key modulation techniques and demonstrates their simulation using LabVIEW, providing valuable ...

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 2025 ...

Qingyun Pan shares how data-informed choices shaped the development, casting, and visual style of Loser is Winner, a ...